NEUTRALIZATION OF IMMUNOSUPPRESSION BY ANTIBODIES AGAINST VARIABLE AS WELL AS CONSTANT REGIONS OF MONOCLONAL ANTI-THY-1 XENOANTIBODIES AND THEIR ABILITY TO BE SUPPRESSED BY INITIAL T CELL DEPLETION
- 1 April 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 47 (4) , 641-646
- https://doi.org/10.1097/00007890-198904000-00015
Abstract
Timing, magnitude, and effect of the murine antibody response to rat pan-T-cell antibodies were studied in a bone marrow (C57BL/6-to-CBA mice) transplantation model. Prospective C57BL/6 marrow donor mice were sensitized against pan-T-cell (Thy-1, Thy-1.2, Lyt-1) monoclonal antibodies of various rat isotypes or against polyclonal rat antimouse-thymocytes (rat ATG) antibodies. Three days prior to transfer of spleen and bone marrow cells, the sensitized C57BL/6 donors received a dose of anti-Thy-1 mAb (RmT1) known to abolish graft-versus-host reactivity of unsensitized donors. The injected mAb provoked anti-antibodies reacting with RmT1. The anti-antibodies inhibited immunosuppression of the rat mAb RmT1 even if they bound only to nonidiotypic epitopes on RmT1. Avoiding cell-binding of the sensitizing rat anti-Thy-1.2 mAb by its injection into Thy-1.1 mice induced only low -titer and delayed anti-antibodies. This indicated the enhanced immunization potential of anti-Thy-1 when bound to cells. Finally, sensitization leading to the mouse antirat anti-antibodies and reversion of immunosuppression was prevented or reduced considerably by T cell depletion with a mosue IgG2a anti-Thy-1.2 mAb or high-dose cyclophosphamide or by rabbit ATG, provided it was initiated before starting the sensitizing injections of the rat antimouse T cell antibodies.This publication has 12 references indexed in Scilit:
- ANTILYMPHOCYTIC ANTIBODIES AND MARROW TRANSPLANTATION .8. RECIPIENT CONDITIONING WITH CLQ-AFFINE MONOCLONAL ANTI-PAN T-ANTIBODIES PREVENTS GVHD IN HOMOZYGOUS FULLY MISMATCHED MICE1986
- PROPHYLACTIC USE OF OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY RECIPIENTS UTILIZATION OF OKT3 AS THE SOLE IMMUNOSUPPRESSIVE AGENTTransplantation, 1986
- Tolerance to rat monoclonal antibodies. Implications for serotherapy.The Journal of Experimental Medicine, 1986
- ANTI-IDIOTYPIC AND NON-ANTI-INDIOTYPIC ANTIBODIES TO OKT3 ARISING DESPITE INTENSE IMMUNOSUPPRESSIONTransplantation, 1986
- ANTILYMPHOCYTIC ANTIBODIES AND MARROW TRANSPLANTATION .7. 2 OF 9 MONOCLONAL ANTI-THY-1 ANTIBODIES USED FOR PRETREATMENT OF DONOR MARROW SUPPRESSED GRAFT-VERSUS-HOST REACTIONS WITHOUT ADDED COMPLEMENT1985
- Unusually restricted anti‐isotype human immune response to OKT3 monoclonal antibodyEuropean Journal of Immunology, 1984
- MONOCLONAL-ANTIBODY THERAPEUTIC TRIALS IN 7 PATIENTS WITH T-CELL LYMPHOMA1983
- Monoclonal Antibodies Specific for Rat IgG1, IgG2a, and IgG2b Subclasses, and Kappa Chain Monotypic and Allotypic Determinants: Reagents for Use with Rat Monoclonal AntibodiesHybridoma, 1982
- T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.The Journal of Experimental Medicine, 1980
- ANTIBODY RESPONSE TO HORSE γ-GLOBULIN IN RECIPIENTS OF RENAL ALLOGRAFTSTransplantation, 1977